Additionally, the identification of bromodomain-containing 7 (BRD7), a negative regulator of cell proliferation and growth, represses the AR transactivation activity induced by TRIM24 and contributing to the modulation of prostate cancer pathogenesis [58]. This evidence concerns the gene BRD7 and prostate carcinoma.